Avalo Therapeutics (AVTX) announced the expansion of its leadership team with two senior appointments: Taylor Boyd has been named Chief Business Officer, CBO, and Ashley Ivanowicz has joined as Senior Vice President, Human Resources.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTX:
- Avalo Therapeutics Appoints Kevin Lind to Board
- Avalo Therapeutics appoints Kevin Lind to board of directors
- Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
- Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
- 3 Best Stocks to Buy Now, 9/12/2025, According to Top Analysts